Our CSO Dr. Ioannis Tarnanas who is a researcher in neurodegenerative diseases at ETH Zurich, explains how new technologies and apps can help Alzheimer’s patients and how they can be used as screening tools.  ­

Next Generation Medicine at Hirslanden Kliniken Zurich, Switzerland